Christoph Martin Hoock

Title: Christoph Martin Hoock: Innovator in Multicomponent Crystals

Introduction

Christoph Martin Hoock is a notable inventor based in Dresden, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel multicomponent crystals. With a total of four patents to his name, Hoock's work focuses on innovative solutions for pain management.

Latest Patents

Hoock's latest patents include the creation of multicomponent crystals made from ([2-amino-6-(4-fluoro-benzylamino)-pyridin-3-yl]-carbamic acid ethyl ester and 2-[2-[(2,6-dichlorphenyl)-amino]-phenyl]-acetic acid. This invention relates to the production and use of these crystals for treating pain conditions, particularly those of unclear genesis. The crystals are designed to address pain caused by muscle tension, degenerative joint diseases, and inflammatory processes. Another patent involves multicomponent crystals made from ([2-amino-6-(4-fluoro-benzylamino)-pyridin-3-yl]-carbamic acid ethyl ester and an arylpropionic acid, which also aims to provide effective pain relief.

Career Highlights

Throughout his career, Christoph Martin Hoock has worked with prominent companies in the pharmaceutical industry, including Teva GmbH and Teva Pharmaceuticals USA, Inc. His experience in these organizations has contributed to his expertise in the development of innovative pharmaceutical solutions.

Collaborations

Hoock has collaborated with notable colleagues such as Asal Qadan and Bernd Terhaag. These partnerships have likely enhanced his research and development efforts in the field of multicomponent crystals.

Conclusion

Christoph Martin Hoock is a distinguished inventor whose work in multicomponent crystals has the potential to revolutionize pain management therapies. His innovative patents and collaborations reflect his commitment to advancing pharmaceutical science.